Cornerstone Robotics

Medtronic Invests $700M in Cornerstone Robotics for Global Sentire Rights

Hong Kong – September 7, 2026 -- Medtronic (NYSE: MDT) will invest approximately $700 million in Hong Kong-based Cornerstone Robotics as part of a strategic partnership granting the medical device giant distribution rights to the SentireTM surgical robot in markets outside the United States where the system holds regulatory clearance.

Medtronic secures distribution rights for Sentire outside the US

The agreement gives Medtronic access to Cornerstone Robotics' surgical robotics platform in territories where Sentire has already received market authorization, adding to the company's existing Hugo robotic surgery platform. Matt Anderson, Senior Vice President and President of the Surgery division at Medtronic, said the deal strengthens the company's capacity to widen access to minimally invasive surgery and that Sentire complements the Hugo platform.

Medtronic Invests $700M in Cornerstone Robotics for Surgical Robot Rights

Hong Kong – September 07, 2026 -- Medtronic (NYSE: MDT) will invest approximately $700 million in Hong Kong-based Cornerstone Robotics as part of a strategic partnership granting the medtech giant distribution rights to Cornerstone's Sentire surgical robot in select markets outside the United States.

Medtronic secures rights to distribute Sentire in cleared ex-US markets

Under the agreement, Medtronic gains rights to sell the Sentire surgical system in markets where it has already received regulatory clearance. The Sentire system obtained National Medical Products Administration approval in China in 2024, followed by CE marking in the European Union and Health Sciences Authority approval in Singapore in May 2026. All three approvals cover minimally invasive general, gynecological, thoracic and urological procedures.

Medtronic to Invest $700M in Cornerstone Robotics for Sentire Rights

Hong Kong – September 07, 2026 -- Medtronic (NYSE: MDT) will invest approximately $700 million in Hong Kong-based Cornerstone Robotics as part of a strategic alliance granting the U.S. medtech giant distribution rights to the Sentire surgical robotic system in select markets outside the United States where the device is approved.

Medtronic gains distribution rights to Sentire outside the U.S.

The agreement covers markets where Sentire has already secured regulatory clearance, positioning the system alongside Medtronic's existing Hugo robotic surgical platform. Sentire received approval from China's National Medical Products Administration in 2024, followed by CE marking in the European Union and clearance from Singapore's Health Sciences Authority in May 2026 for general, gynecological, thoracic and urological minimally invasive procedures.